Skip to main content

Peer Review reports

From: Safety, efficacy, and compliance of moderate-to-high dose eptinezumab and erenumab in chronic migraine patients with medication-overuse headache: an updated systematic review and meta-analysis

Original Submission
27 Jan 2025 Submitted Original manuscript
4 Mar 2025 Reviewed Reviewer Report
10 Mar 2025 Reviewed Reviewer Report
12 Mar 2025 Reviewed Reviewer Report
3 Apr 2025 Author responded Author comments - Nhan Nguyen
Resubmission - Version 2
3 Apr 2025 Submitted Manuscript version 2
Publishing
24 Apr 2025 Editorially accepted
6 May 2025 Article published 10.1186/s10194-025-02047-7

You can find further information about peer review here.

Back to article page